Bionik Laboratories Corp.
BNKL
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.25K
Close$
Share Statistics
| Market cap | $1,248.00 |
|---|---|
| Enterprise Value | $2.33 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.72 |
| Beta | 9.36 |
| Outstanding Shares | 6,968,299 |
Return
| Return on Equity | 308.85% |
|---|---|
| Return on Assets | -150.71% |
| Return on Invested Capital | -459.56% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1.29 |
| Enterprise Value to EBIT | -0.48 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.18 |
| Debt to Equity | -1.68 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bionik Laboratories Corp.
12 employees
CEO: Richard Paul Russo Jr. Bionik Laboratories Corp. operates as a robotics firm, focusing on the innovation, development, and market introduction of advanced solutions for physical rehabilitation, prosthetic devices, and assistive robotics. The company's product ...